KELSEY GLAZIER: Open Payments
NPI 1336789718 · SAPULPA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,168 in 86 payments from 13 companies in 2025. Trend: 2023 $609 · 2024 $3,942 · 2025 $2,168
Food & beverage: $2,168
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 11 | $302 |
| Janssen Biotech, Inc. | 10 | $292 |
| PFIZER INC. | 18 | $291 |
| Regeneron Healthcare Solutions, Inc. | 8 | $277 |
| Amgen Inc. | 7 | $273 |
| ABBVIE INC. | 12 | $264 |
| Novartis Pharmaceuticals Corporation | 4 | $147 |
| Organon LLC | 7 | $140 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $63 |
| Lilly USA, LLC | 2 | $33 |
Products named: Zoryve, TREMFYA, CIBINQO, OTEZLA, DUPIXENT, RINVOQ, COSENTYX, VTAMA.
Industry payments across OK — which companies pay providers there.
